INDIANAPOLIS (WISH) — Hoosiers can celebrate Hispanic Heritage Month with a special “Shining a Light” presentation on Monument Circle. “Shining a Light” is a vibrant light and multimedia presentation ...

SAN FRANCISCO, September 25, 2025--(BUSINESS WIRE)--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today ...

INDIANAPOLIS (WISH) — Hoosiers can continue to celebrate the legacy of Dr. Martin Luther King Jr. with a special tribute for Black History Month. “Shining a Light” is a vibrant light and video show ...

SAN FRANCISCO--(BUSINESS WIRE)--Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, today announced an upcoming poster ...

Cyclin D1 is overexpressed in certain solid tumors and hematologic malignancies. In these cancers, the cyclin D1/CDK4 complex drives cell proliferation by binding to the tumor suppressor ...

The Hestia Women's Giving Circle has announced its 2025-26 Learning Series, which will focus on community needs and issues ...

Telecom operators are piloting a new feature called Calling Name Presentation. This will allow users to see a caller's name ...

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced an upcoming poster presentation highlighting the ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced an upcoming poster presentation highlighting the ...